866-997-4948(US-Canada Toll Free)

Published on : Nov 24, 2016

ALBANY, NY, Nov 24, 2016: A new research report on the global market for erythropoietin has been recently added to the vast repository of ResearchMoz.us. The market study, titled “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020),” presents an all-inclusive and unbiased analysis of this market, taking its current status, historical performance, and future prospects into consideration.

As per the study, the global market for erythropoietin drugs is likely to witness declining growth in the coming years due to the imminent patent expiry of the two of the most common erythropoietin drugs, darbepoetin-alfa and epoetin-alfa. Apart from this, the advent of biosimilars is also expected to pose a serious threat to the progression of the worldwide market for erythropoietin drugs over the forecast period.

Contrary to this, the market for erythropoietin in Asia Pacific is estimated to register a remarkable rise in the coming years due to the improvement in the government medical reimbursement policies and the increasing disposable income of consumers in this regions, states the research report.

To prepare this 72- page report, researchers have studied the global market for erythropoietin on the basis of key driving factors, challenges, market trends, and opportunities. Important statistical data regarding this market has also been presented with the help of 350 tables and figures in this study, which makes it a valuable source of guidance for enterprises and stakeholders functioning in the global market for erythropoietin drugs.

Click to get more details with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=862810

The report provides a detailed information on the manufacturing volume, pricing strategies, the dynamics of demand and supply, gross margin, data related to import/export, and the revenue generated in this market. Researchers have also calculated the market’s growth rate in order to determine the overall market value by the end of the forecast period.

Predominantly, the research report has assessed the global market for erythropoietin drugs on the basis of their molecular structure. According to the study, these drugs can be segmented into darbepoetin-alfa, epoetin-alfa, epoetin-beta, epoetin-omega, and epoetin-delta. Among these, the demand for darbepoetin-alfa and epoetin-alfa is witnessing a greater demand than other erythropoietin drugs, states the market study.

The global market for erythropoietin has also been assessed on the basis of its competitive landscape in this research report. Researchers have examined the profiles of the key players thoroughly in order to determine the current hierarchy of this market. As per the study, Johnson & Johnson, F. Hoffmann-La Roche AG, Amgen, and Teva Pharmaceutical Industries Ltd. are the leading players operating in the global market for erythropoietin.

These players have been investing heavily in research and development activities in a bid to develop innovative and technologically advanced products. On account of the high rivalry between the participants, the market is witnessing a series of new launches and the trend is projected to continue throughout the forecast period, driving immense growth in the global market for erythropoietin, states the research report.

To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on sales@researchmoz.us